Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air((R)) approach

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F23%3A00077881" target="_blank" >RIV/65269705:_____/23:00077881 - isvavai.cz</a>

Výsledek na webu

<a href="https://onlinelibrary.wiley.com/doi/epdf/10.1002/clt2.12215" target="_blank" >https://onlinelibrary.wiley.com/doi/epdf/10.1002/clt2.12215</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/clt2.12215" target="_blank" >10.1002/clt2.12215</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air((R)) approach

Popis výsledku v původním jazyce

MASK-air((R)), a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK-air((R)) is a Good Practice of DG Sante on digitally-enabled, patient-centred care. It is also a candidate Good Practice of OECD (Organisation for Economic Co-operation and Development). MASK-air((R)) data has enabled novel phenotype discovery and characterisation, as well as novel insights into the management of allergic rhinitis. MASK-air((R)) data show that most rhinitis patients (i) are not adherent and do not follow guidelines, (ii) use as-needed treatment, (iii) do not take medication when they are well, (iv) increase their treatment based on symptoms and (v) do not use the recommended treatment. The data also show that control (symptoms, work productivity, educational performance) is not always improved by medications. A combined symptom-medication score (ARIA-EAACI-CSMS) has been validated for clinical practice and trials. The implications of the novel MASK-air((R)) results should lead to change management in rhinitis and asthma.

Název v anglickém jazyce

Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air((R)) approach

Popis výsledku anglicky

MASK-air((R)), a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK-air((R)) is a Good Practice of DG Sante on digitally-enabled, patient-centred care. It is also a candidate Good Practice of OECD (Organisation for Economic Co-operation and Development). MASK-air((R)) data has enabled novel phenotype discovery and characterisation, as well as novel insights into the management of allergic rhinitis. MASK-air((R)) data show that most rhinitis patients (i) are not adherent and do not follow guidelines, (ii) use as-needed treatment, (iii) do not take medication when they are well, (iv) increase their treatment based on symptoms and (v) do not use the recommended treatment. The data also show that control (symptoms, work productivity, educational performance) is not always improved by medications. A combined symptom-medication score (ARIA-EAACI-CSMS) has been validated for clinical practice and trials. The implications of the novel MASK-air((R)) results should lead to change management in rhinitis and asthma.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30225 - Allergy

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Clinical and Translational Allergy

ISSN

2045-7022

e-ISSN

2045-7022

Svazek periodika

13

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

30

Strana od-do

"e12215"

Kód UT WoS článku

000928174400001

EID výsledku v databázi Scopus

2-s2.0-85147105865